Vlado Perkovic

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 27

Top Topics

Systematic Review

Chronic Kidney Disease

Top Venues

Journal of the American Heart Association

Diabetes, obesity & metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Brendon L Neuen, Brian Lee Claggett, Vlado Perkovic, Meg J Jardine, Hiddo J Lambers Heerspink, Kenneth W Mahaffey, John Joseph Valentine McMurray, Scott D Solomon, Muthiah Vaduganathan
Timing of Cardio-Kidney Protection With SGLT2 Inhibitors: Insights From 4 Large-Scale Placebo-Controlled Outcome Trials. Circulation 150 (4) (2024)
Abhinav Sharma, Amir Razaghizad, Abdulaziz Joury, Adeera Levin, Harpreet S Bajaj, G B John Mancini, Norman C Wong, April E Hebert, Fernando G Ang, Wally Rapattoni, Brendon L Neuen, Clare Arnott, Vlado Perkovic, Kenneth W Mahaffey
Primary and Secondary Cardiovascular and Kidney Prevention With Canagliflozin: Insights From the CANVAS Program and CREDENCE Trial. Journal of the American Heart Association 13 (3) (2024)
Brendon L Neuen, Robert A Fletcher, Lauren Heath, Adam Perkovic, Muthiah Vaduganathan, Sunil V Badve, Katherine R Tuttle, Richard E Pratley, Ulagamadesan Venkatesan, Vlado Perkovic, Hiddo J Lambers Heerspink
Cardiovascular, Kidney and Safety Outcomes with GLP-1 Receptor Agonists Alone and in Combination with SGLT2 Inhibitors in Type 2 Diabetes: A Systematic Review and Meta-Analysis. Circulation (2024)
Abhinav Sharma, Amir Razaghizad, Abdulaziz Joury, Adeera Levin, Harpreet S Bajaj, G B John Mancini, Norman C Wong, April E Hebert, Fernando G Ang, Wally Rapattoni, Brendon L Neuen, Clare Arnott, Vlado Perkovic, Kenneth W Mahaffey
Primary and Secondary Cardiovascular and Kidney Prevention With Canagliflozin: Insights From the CANVAS Program and CREDENCE Trial. Journal of the American Heart Association 13 (3) (2024)
Siddharth M Patel, Yu Mi Kang, KyungAh Im, Brendon L Neuen, Stefan D Anker, Deepak L Bhatt, Javed Butler, David Z I Cherney, Brian Lee Claggett, Robert A Fletcher, William G Herrington, Catherine M Viscoli, Meg J Jardine, Kenneth W Mahaffey, Darren K McGuire, John Joseph Valentine McMurray, Bruce C Neal, Milton Packer, Vlado Perkovic, Scott D Solomon, Natalie Staplin, Muthiah Vaduganathan, Christoph Wanner, David Collins Wheeler, Faiez Zannad, Yujie Zhao, Hiddo J Lambers Heerspink, Marc S Sabatine, Stephen D Wiviott
Sodium-Glucose Cotransporter-2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis. Circulation 149 (23) (2024)
Siddharth M Patel, Yu Mi Kang, KyungAh Im, Brendon L Neuen, Stefan D Anker, Deepak L Bhatt, Javed Butler, David Z I Cherney, Brian Lee Claggett, Robert A Fletcher, William G Herrington, Catherine M Viscoli, Meg J Jardine, Kenneth W Mahaffey, Darren K McGuire, John Joseph Valentine McMurray, Bruce C Neal, Milton Packer, Vlado Perkovic, Scott D Solomon, Natalie Staplin, Muthiah Vaduganathan, Christoph Wanner, David Collins Wheeler, Faiez Zannad, Yujie Zhao, Hiddo J Lambers Heerspink, Marc S Sabatine, Stephen D Wiviott
Sodium Glucose Co-transporter 2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis. Circulation (2024)
Siddharth M Patel, Yu Mi Kang, KyungAh Im, Brendon L Neuen, Stefan D Anker, Deepak L Bhatt, Javed Butler, David Z I Cherney, Brian Lee Claggett, Robert A Fletcher, William G Herrington, Catherine M Viscoli, Meg J Jardine, Kenneth W Mahaffey, Darren K McGuire, John Joseph Valentine McMurray, Bruce C Neal, Milton Packer, Vlado Perkovic, Scott D Solomon, Natalie Staplin, Muthiah Vaduganathan, Christoph Wanner, David Collins Wheeler, Faiez Zannad, Yujie Zhao, Hiddo J Lambers Heerspink, Marc S Sabatine, Stephen D Wiviott
Sodium-Glucose Cotransporter-2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis. Circulation 149 (23) (2024)
Abhinav Sharma, Amir Razaghizad, Abdulaziz Joury, Adeera Levin, Harpreet S Bajaj, G B John Mancini, Norman C Wong, April E Hebert, Fernando G Ang, Wally Rapattoni, Brendon L Neuen, Clare Arnott, Vlado Perkovic, Kenneth W Mahaffey
Primary and Secondary Cardiovascular and Kidney Prevention With Canagliflozin: Insights From the CANVAS Program and CREDENCE Trial. Journal of the American Heart Association 13 (3) (2024)
Abhinav Sharma, Amir Razaghizad, Abdulaziz Joury, Adeera Levin, Harpreet S Bajaj, G B John Mancini, Norman C Wong, April E Hebert, Fernando G Ang, Wally Rapattoni, Brendon L Neuen, Clare Arnott, Vlado Perkovic, Kenneth W Mahaffey
Primary and Secondary Cardiovascular and Kidney Prevention With Canagliflozin: Insights From the CANVAS Program and CREDENCE Trial. Journal of the American Heart Association (2024)
Abhinav Sharma, Amir Razaghizad, Abdulaziz Joury, Adeera Levin, Harpreet S Bajaj, G B John Mancini, Norman C Wong, April E Hebert, Fernando G Ang, Wally Rapattoni, Brendon L Neuen, Clare Arnott, Vlado Perkovic, Kenneth W Mahaffey
Primary and Secondary Cardiovascular and Kidney Prevention With Canagliflozin: Insights From the CANVAS Program and CREDENCE Trial. Journal of the American Heart Association 13 (3) (2024)
Brendon L Neuen, Brian Lee Claggett, Vlado Perkovic, Meg J Jardine, Hiddo J Lambers Heerspink, Kenneth W Mahaffey, John Joseph Valentine McMurray, Scott D Solomon, Muthiah Vaduganathan
Timing of Cardio-Kidney Protection With SGLT2 Inhibitors: Insights From Four Large-Scale Placebo-Controlled Outcome Trials. Circulation (2024)
Siddharth M Patel, Yu Mi Kang, KyungAh Im, Brendon L Neuen, Stefan D Anker, Deepak L Bhatt, Javed Butler, David Z I Cherney, Brian Lee Claggett, Robert A Fletcher, William G Herrington, Catherine M Viscoli, Meg J Jardine, Kenneth W Mahaffey, Darren K McGuire, John Joseph Valentine McMurray, Bruce C Neal, Milton Packer, Vlado Perkovic, Scott D Solomon, Natalie Staplin, Muthiah Vaduganathan, Christoph Wanner, David Collins Wheeler, Faiez Zannad, Yujie Zhao, Hiddo J Lambers Heerspink, Marc S Sabatine, Stephen D Wiviott
Sodium-Glucose Cotransporter-2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis. Circulation 149 (23) (2024)
Siddharth M Patel, Yu Mi Kang, KyungAh Im, Brendon L Neuen, Stefan D Anker, Deepak L Bhatt, Javed Butler, David Z I Cherney, Brian Lee Claggett, Robert A Fletcher, William G Herrington, Catherine M Viscoli, Meg J Jardine, Kenneth W Mahaffey, Darren K McGuire, John Joseph Valentine McMurray, Bruce C Neal, Milton Packer, Vlado Perkovic, Scott D Solomon, Natalie Staplin, Muthiah Vaduganathan, Christoph Wanner, David Collins Wheeler, Faiez Zannad, Yujie Zhao, Hiddo J Lambers Heerspink, Marc S Sabatine, Stephen D Wiviott
Sodium Glucose Co-transporter 2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis. Circulation (2024)
Siddharth M Patel, Yu Mi Kang, KyungAh Im, Brendon L Neuen, Stefan D Anker, Deepak L Bhatt, Javed Butler, David Z I Cherney, Brian Lee Claggett, Robert A Fletcher, William G Herrington, Catherine M Viscoli, Meg J Jardine, Kenneth W Mahaffey, Darren K McGuire, John Joseph Valentine McMurray, Bruce C Neal, Milton Packer, Vlado Perkovic, Scott D Solomon, Natalie Staplin, Muthiah Vaduganathan, Christoph Wanner, David Collins Wheeler, Faiez Zannad, Yujie Zhao, Hiddo J Lambers Heerspink, Marc S Sabatine, Stephen D Wiviott
Sodium-Glucose Cotransporter-2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis. Circulation 149 (23) (2024)
James L Januzzi, Reza Mohebi, Yuxi Liu, Naveed Sattar, Hiddo J Lambers Heerspink, Eshetu Tefera, Muthiah Vaduganathan, Javed Butler, Yshai Yavin, Jingwei Li, Carol A Pollock, Vlado Perkovic, Bruce C Neal, Michael K Hansen
Cardiorenal Biomarkers, Canagliflozin, and Outcomes in Diabetic Kidney Disease: The CREDENCE Trial. Circulation 148 (8) (2023)
Robert A Fletcher, Clare Arnott, Patrick Rockenschaub, Aletta Elisabeth Schutte, Lewis Carpenter, Muthiah Vaduganathan, Rajiv Agarwal, George L Bakris, Tara I-Hsin Chang, Hiddo J Lambers Heerspink, Meg J Jardine, Kenneth W Mahaffey, Bruce C Neal, Carol A Pollock, Min Jun, Anthony Rodgers, Vlado Perkovic, Brendon L Neuen
Canagliflozin, Blood Pressure Variability, and Risk of Cardiovascular, Kidney, and Mortality Outcomes: Pooled Individual Participant Data From the CANVAS and CREDENCE Trials. Journal of the American Heart Association (2023)
Abhinav Sharma, Pedro Marques, Brendon L Neuen, Robert A Fletcher, April E Hebert, Wally Rapattoni, Fernando G Ang, Clare Arnott, Adeera Levin, Subodh Verma, Vlado Perkovic, Kenneth W Mahaffey
Timing of statistical benefit of canagliflozin in patients with type 2 diabetes for cardiovascular and heart failure outcomes: Insights from the CANVAS Program and CREDENCE trial. Diabetes, obesity & metabolism (2023)
Brendon L Neuen, Hiddo J Lambers Heerspink, Priya Vart, Brian Lee Claggett, Robert A Fletcher, Clare Arnott, Juliana de Oliveira Costa, Michael O Falster, Sallie-Anne Pearson, Kenneth W Mahaffey, Bruce C Neal, Rajiv Agarwal, George L Bakris, Vlado Perkovic, Scott D Solomon, Muthiah Vaduganathan
Estimated Lifetime Cardiovascular, Kidney and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Non-steroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria. Circulation (2023)
Jing-Wei Li, Clare Arnott, Hiddo J Lambers Heerspink, Qiang Li MBiostat, Christopher P Cannon, David Collins Wheeler, David M Charytan, Jennifer Barraclough, Gemma A Figtree, Rajiv Agarwal, George L Bakris, Dick de Zeeuw, Tom Greene, Adeera Levin, Carol A Pollock, Hong Zhang, Bernard Zinman, Kenneth W Mahaffey, Vlado Perkovic, Bruce C Neal, Meg J Jardine
Effect of Canagliflozin on Total Cardiovascular Burden in Patients With Diabetes and Chronic Kidney Disease: A Post Hoc Analysis From the CREDENCE Trial. Journal of the American Heart Association 11 (16) (2022)
Brendon L Neuen, Megumi Oshima, Rajiv Agarwal, Clare Arnott, David Z I Cherney, Robert Edwards, Anna Maria Langkilde, Kenneth W Mahaffey, Darren K McGuire, Bruce C Neal, Vlado Perkovic, Annpey Pong, Marc S Sabatine, Itamar Raz, Tadashi Toyama, Christoph Wanner, David Collins Wheeler, Stephen D Wiviott, Bernard Zinman, Hiddo J Lambers Heerspink
Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Hyperkalemia in People With Type 2 Diabetes: A Meta-Analysis of Individual Participant Data From Randomized, Controlled Trials. Circulation 145 (19) (2022)
Eleuterio Ferrannini, Simona Baldi, Tiziana Scozzaro, Vasilis Tsimihodimos, Fisseha Tesfaye, Wayne Shaw, Norman Rosenthal, Gemma A Figtree, Bruce C Neal, Kenneth W Mahaffey, Vlado Perkovic, Michael K Hansen
Fasting Substrate Concentrations Predict Cardiovascular Outcomes in the CANagliflozin cardioVascular Assessment Study (CANVAS). Diabetes care 45 (8) (2022)
Katherine M Wang, JingWei Li, Vivek Bhalla, Meg J Jardine, Bruce C Neal, Dick de Zeeuw, Greg Fulcher, Vlado Perkovic, Kenneth W Mahaffey, Tara I-Hsin Chang
Canagliflozin, serum magnesium and cardiovascular outcomes-Analysis from the CANVAS Program. Endocrinology, diabetes & metabolism 4 (3) (2021)
Ahmed M Shaman, Stephen C Bain, George L Bakris, John B Buse, Thomas Idorn, Kenneth W Mahaffey, Johannes F E Mann, Michael A Nauck, Søren Rasmussen, Peter Rossing, Benjamin Wolthers, Bernard Zinman, Vlado Perkovic
Effect of the Glucagon-Like Peptide-1 Receptor Agonists Semaglutide and Liraglutide on Kidney Outcomes in Patients With Type 2 Diabetes: Pooled Analysis of SUSTAIN 6 and LEADER. Circulation 145 (8) (2021)
Brendon L Neuen, Megumi Oshima, Vlado Perkovic, Rajiv Agarwal, Clare Arnott, George L Bakris, Christopher P Cannon, David M Charytan, Robert Edwards, Jose Luis Gorriz Teruel, Meg J Jardine, Adeera Levin, Bruce C Neal, Luca De Nicola, Carol A Pollock, Norman Rosenthal, David Collins Wheeler, Kenneth W Mahaffey, Hiddo J L Heerspink
Effects of canagliflozin on serum potassium in people with diabetes and chronic kidney disease: the CREDENCE trial. European heart journal (2021)
Vlado Perkovic, Robert Toto, Mark E Cooper, Johannes F E Mann, Julio Rosenstock, Darren K McGuire, Steven E Kahn, Nikolaus Marx, John H Alexander, Bernard Zinman, Egon Pfarr, Sven Schnaidt, Thomas Meinicke, Maximillian von Eynatten, Jyothis T George, Odd Erik Johansen, Christoph Wanner, null null
Effects of Linagliptin on Cardiovascular and Kidney Outcomes in People With Normal and Reduced Kidney Function: Secondary Analysis of the CARMELINA Randomized Trial. Diabetes care 43 (8) (2020)
Daniel V O'Hara, Thomas R Parkhill, Sunil V Badve, Min Jun, Meg J Jardine, Vlado Perkovic
The effects of dipeptidyl peptidase-4 inhibitors on kidney outcomes. Diabetes, obesity & metabolism 23 (3) (2020)
Min Jun, Meg J Jardine, Vlado Perkovic, Quentin Pilard, Laurent Billot, Anthony Rodgers, Kris Rogers, Martin Gallagher
Hyperkalemia and renin-angiotensin aldosterone system inhibitor therapy in chronic kidney disease: A general practice-based, observational study. PloS one 14 (3) (2019)